Egalet Received a Grant from InnoBooster to Develop a Novel Application of Guardian™ Technology

Egalet Logo. (PRNewsFoto/Egalet Corporation)WAYNE, Pa., Nov. 20, 2017 /PRNewswire/ — Egalet Corporation (Nasdaq: EGLT) (Egalet), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, today announced the company was awarded a…

PR NEWSWIRE

About M Fund

SITE ADMIN